Has results × Bronchiolitis Obliterans Syndrome × Lymphoid × Clear all A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy
Phase 1/2 Completed
24 enrolled 67 charts
REACH 5
Phase 2 Completed
46 enrolled 21 charts
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Phase 1/2 Completed
95 enrolled 13 charts
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
Phase 1/2 Completed
96 enrolled 13 charts
Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL
Phase 1/2 Completed
260 enrolled 33 charts
RESONATEâ„¢
Phase 3 Completed
391 enrolled 14 charts
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Phase 2 Completed
271 enrolled 32 charts
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Phase 3 Completed
266 enrolled 58 charts
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
666 enrolled 110 charts
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
1,101 enrolled 46 charts
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
Phase 2 Completed
15 enrolled 10 charts
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Terminated
2,867 enrolled 77 charts
Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
Phase 2 Terminated
11 enrolled 4 charts
A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease
Phase 1 Completed
48 enrolled 27 charts
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
Phase 2 Completed
65 enrolled 8 charts
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Phase 3 Completed
95 enrolled 37 charts
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
901 enrolled 56 charts
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
960 enrolled 55 charts
Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
Phase 2 Completed
86 enrolled 15 charts